Editorial (Management of Pancreatic Cancer)1
Pancreas cancer, careful improvements and human connections
Journal of Gastrointestinal Oncology
2018;
9
(6)
:979-981
.
(01 December 2018)
Original Article (Management of Pancreatic Cancer)1
Chemoradiation after FOLFIRINOX for borderline resectable or locally advanced pancreatic cancer
Journal of Gastrointestinal Oncology
2018;
9
(6)
:982-988
.
(01 December 2018)
Daily breathing inconsistency in pancreas SBRT: a 4DCT study
Journal of Gastrointestinal Oncology
2018;
9
(6)
:989-995
.
(01 December 2018)
Review Article (Management of Pancreatic Cancer)1
Large database utilization in health outcomes research in pancreatic cancer: an update
Journal of Gastrointestinal Oncology
2018;
9
(6)
:996-1004
.
(01 December 2018)
The role of lineage specifiers in pancreatic ductal adenocarcinoma
Journal of Gastrointestinal Oncology
2018;
9
(6)
:1005-1013
.
(01 December 2018)
Combination immunotherapy and radiation therapy strategies for pancreatic cancer—targeting multiple steps in the cancer immunity cycle
Journal of Gastrointestinal Oncology
2018;
9
(6)
:1014-1026
.
(01 December 2018)
Review and current state of radiation therapy for locally advanced pancreatic adenocarcinoma
Journal of Gastrointestinal Oncology
2018;
9
(6)
:1027-1036
.
(01 December 2018)
Advances in surgery for pancreatic cancer
Journal of Gastrointestinal Oncology
2018;
9
(6)
:1037-1043
.
(01 December 2018)
Hypoxia imaging in upper gastrointestinal tumors and application to radiation therapy
Journal of Gastrointestinal Oncology
2018;
9
(6)
:1044-1053
.
(01 December 2018)
Original Article
Pilot evaluation of PD-1 inhibition in metastatic cancer patients with a history of liver transplantation: the Mayo Clinic experience
Journal of Gastrointestinal Oncology
2018;
9
(6)
:1054-1062
.
(01 December 2018)
A SEER-based multi-ethnic picture of advanced intrahepatic cholangiocarcinoma in the United States pre- and post-the advent of gemcitabine/cisplatin
Journal of Gastrointestinal Oncology
2018;
9
(6)
:1063-1073
.
(01 December 2018)
Tailored treatment of patients with hepatocellular carcinoma with portal vein invasion: experience from a multidisciplinary hepatobiliary tumor program within a NCI comprehensive cancer center
Journal of Gastrointestinal Oncology
2018;
9
(6)
:1074-1083
.
(01 December 2018)
External validation of the 8th American Joint Committee on Cancer staging system for gall bladder carcinoma
Journal of Gastrointestinal Oncology
2018;
9
(6)
:1084-1090
.
(01 December 2018)
Stage II–III colon cancer: a comparison of survival calculators
Journal of Gastrointestinal Oncology
2018;
9
(6)
:1091-1098
.
(01 December 2018)
Correlation between vascular endothelial growth factor-A expression and tumor location and invasion in patients with colorectal cancer
Journal of Gastrointestinal Oncology
2018;
9
(6)
:1099-1108
.
(01 December 2018)
Demographic disparities in delay of definitive chemoradiation for anal squamous cell carcinoma: a nationwide analysis
Journal of Gastrointestinal Oncology
2018;
9
(6)
:1109-1126
.
(01 December 2018)
Survey results of US radiation oncology providers’ contextual engagement of watch-and-wait beliefs after a complete clinical response to chemoradiation in patients with local rectal cancer
Journal of Gastrointestinal Oncology
2018;
9
(6)
:1127-1132
.
(01 December 2018)
The relationship between aspirin use and mortality in colorectal cancer
Journal of Gastrointestinal Oncology
2018;
9
(6)
:1133-1137
.
(01 December 2018)
A Simplified Peritoneal Sarcomatosis Score for patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
Journal of Gastrointestinal Oncology
2018;
9
(6)
:1138-1143
.
(01 December 2018)
Prognostic importance of lymph node ratio after resection of ampullary carcinomas
Journal of Gastrointestinal Oncology
2018;
9
(6)
:1144-1149
.
(01 December 2018)
Circulating miRNAs in patients with Barrett’s esophagus, highgrade dysplasia and esophageal adenocarcinoma
Journal of Gastrointestinal Oncology
2018;
9
(6)
:1150-1156
.
(01 December 2018)
Exploring the differences between early-onset gastric cancer and traditional-onset gastric cancer
Journal of Gastrointestinal Oncology
2018;
9
(6)
:1157-1163
.
(01 December 2018)
Krukenberg tumours from gastrointestinal cancers—analysis from a tertiary care centre in India
Journal of Gastrointestinal Oncology
2018;
9
(6)
:1164-1167
.
(01 December 2018)
How many lymph nodes are enough?—defining the extent of lymph node dissection in stage I–III gastric cancer using the National Cancer Database
Journal of Gastrointestinal Oncology
2018;
9
(6)
:1168-1175
.
(01 December 2018)
Supplementation with omega fatty acids increases the mRNA expression level of PLA2G4A in patients with gastric cancer
Journal of Gastrointestinal Oncology
2018;
9
(6)
:1176-1183
.
(01 December 2018)
Expression of miR-520c in intestinal type gastric adenocarcinoma
Journal of Gastrointestinal Oncology
2018;
9
(6)
:1184-1189
.
(01 December 2018)
Transabdominal ultrasonographic features in the diagnosis of gastrointestinal lymphoma
Journal of Gastrointestinal Oncology
2018;
9
(6)
:1190-1197
.
(01 December 2018)
Low ATM expression and progression-free and overall survival in advanced gastric cancer patients treated with first-line XELOX chemotherapy
Journal of Gastrointestinal Oncology
2018;
9
(6)
:1198-1206
.
(01 December 2018)
Case Report
Gastric adenocarcinoma revealed by atypical pulmonary lymphangitic carcinomatosis
Journal of Gastrointestinal Oncology
2018;
9
(6)
:1207-1212
.
(01 December 2018)
Capecitabine-induced hypertriglyceridemia: a rare but clinically relevant treatment-related adverse event
Journal of Gastrointestinal Oncology
2018;
9
(6)
:1213-1219
.
(01 December 2018)
Disclosure:
1. The series “Management of Pancreatic Cancer” was commissioned by the Editorial office, Journal of Gastrointestinal Oncology without any sponsorship or funding. Shane Lloyd served as the unpaid Guest Editor for the series.
